Avalo Therapeutics Inc.
World Rank (Aug-2026)
9,013
Market Cap (Aug-2026)
1.051 Billion USD
World Rank (Jan-05-2024)
31,979
Market Cap (Jan-05-2024)
0.007 Billion USD
World Rank (Jul-30-2023)
33,602
Market Cap (Jul-30-2023)
0.003 Billion USD
World Rank (Dec-25-2022)
25,537
Market Cap (Dec-25-2022)
0.047 Billion USD
World Rank (Jan-07-2022)
21,658
Market Cap (Jan-07-2022)
0.12 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-78 Million USD
Annual Results for Period Ending
For year ending December-2025
Company Profile
Avalo Therapeutics, Inc. is a biopharmaceutical company that discover, develop and commercialize highly targeted therapeutics in areas of significant unmet clinical need. The headquarters is in USA.
Facts About Company
Avalo Therapeutics, Inc. company annual revenue is 18 million USD and annual net loss -41 million USD as on Dec-2022.
Company Website